Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Curr Med Res Opin. 2023 Oct;39(10):1395-1405. doi: 10.1080/03007995.2023.2247969. Epub 2023 Aug 29.
Curr Med Res Opin. 2023.
PMID: 37583267
Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis".
Marshall J, Sharma A, Darken P, Ouwens M, Singh B, Tansey-Dwyer D.
Marshall J, et al. Among authors: tansey dwyer d.
Adv Ther. 2023 May;40(5):2549-2555. doi: 10.1007/s12325-023-02491-4. Epub 2023 Apr 1.
Adv Ther. 2023.
PMID: 37004641
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite